Saturday 17 October 2026
Export VIR’s income statement to Excel — free account
Vir Biotechnology, Inc.
Vir Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $68.6 million, down 7.61% from fiscal 2024. In the quarter to June 2026, revenue grew 19,582.5%, EPS grew 160.0% and free cash flow grew 200.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
9.96
0.51
−4.87%
Follow VIR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 4 | 4 | 5 |
| (49.06%) | (45.73%) | (47.69%) | (26.08%) | ||
| (39.69%) | (36.47%) | (37.95%) | (20.91%) | ||
ROIC |
(119.31%) | (101.09%) | (88.19%) | (39.10%) | |
Return on Tangible Assets |
(94.51%) | (91.84%) | (88.09%) | (47.56%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.29) | (2.86) | (3.05) | (1.21) | |
Free Cash Flow |
(457.20) | (396.36) | (449.67) | (203.67) | |
Capital Expenditures |
(3.66) | (4.58) | (3.62) | (1.16) | |
| Other line items | |||||
Cash ROIC |
(35.04%) | (32.11%) | (34.83%) | (13.42%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.10 | 0.10 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | — | — | |
Average Days of Payables |
3,404.84 | 5,039.57 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2,809.61% | 665.10% | 681.34% | 159.62% | |
Selling, General and Administrative Expense of Revenue |
564.41% | 134.30% | 139.66% | 32.77% | |
Share Based Compensation of Revenue |
318.55% | 71.58% | 71.91% | 15.51% | |
Operating CF/Net income |
0.91 | 0.89 | 1.01 | 0.80 | |
Depreciation/Fixed assets |
0.37 | 0.38 | 0.33 | 0.30 | |
Capex/Depreciation |
(0.17) | (0.22) | (0.21) | (0.08) | |
Revenue per Share |
0.12 | 0.49 | 0.44 | 1.81 | |
Operating CF per Share |
(3.26) | (2.83) | (3.03) | (1.21) | |
Capex per Share |
(0.03) | (0.03) | (0.02) | (0.01) | |
Capex to Sales |
0.22 | 0.07 | 0.06 | 0.00 |
Columns are period end dates